Morgan Stanley’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.5M Sell
611,971
-126,743
-17% -$4.02M ﹤0.01% 3215
2026
Q1
$23.3M Buy
738,714
+123,433
+20% +$3.89M ﹤0.01% 2811
2025
Q4
$18.1M Sell
615,281
-464,286
-43% -$12.9M ﹤0.01% 3032
2025
Q3
$27.3M Buy
1,079,567
+180,480
+20% +$4.4M ﹤0.01% 2581
2025
Q2
$21.6M Buy
899,087
+539,113
+150% +$12.5M ﹤0.01% 2730
2025
Q1
$8.24M Sell
359,974
-339,590
-49% -$8.19M ﹤0.01% 3522
2024
Q4
$17.7M Sell
699,564
-154,426
-18% -$3.91M ﹤0.01% 2880
2024
Q3
$21.3M Sell
853,990
-104,248
-11% -$3.09M ﹤0.01% 2738
2024
Q2
$28.4M Buy
958,238
+118,817
+14% +$3.3M ﹤0.01% 2290
2024
Q1
$25.3M Sell
839,421
-5,839
-0.7% -$162K ﹤0.01% 2436
2023
Q4
$24.2M Sell
845,260
-342,869
-29% -$10.1M ﹤0.01% 2497
2023
Q3
$44M Buy
1,188,129
+219,432
+23% +$8.38M ﹤0.01% 1697
2023
Q2
$37.8M Sell
968,697
-661,482
-41% -$25.9M ﹤0.01% 1852
2023
Q1
$59.5M Sell
1,630,179
-1,199,779
-42% -$37.9M 0.01% 1399
2022
Q4
$87.2M Buy
+2,829,958
New +$87.8M 0.01% 1113

Other funds holding RTO

Morgan Stanley's RTO Position: Q2 2026 in Review

Morgan Stanley reduced its Rentokil (RTO) stake by 17% in Q2 2026, selling an estimated $4.02M and leaving 611,971 shares worth $17.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3215.

Morgan Stanley first reported a position in RTO in Q4 2022 and has held it in 15 quarters since. The position peaked at $87.2M in Q4 2022. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Morgan Stanley held 611,971 shares of Rentokil worth $17.5M as of Q2 2026.
  • Morgan Stanley sold 126,743 Rentokil shares in Q2 2026, an estimated $4.02M.
  • Rentokil made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3215 holding.
  • Morgan Stanley first reported a position in Rentokil in Q4 2022 and has held it in 15 quarters since.
  • Morgan Stanley's Rentokil position peaked at $87.2M in Q4 2022.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.